Journal · Pharmacy records

Which pharmacy fills your GLP-1 program? What FDA's records show for 19 named pharmacies

Released: · Last reviewed: · By Dr. Parmis

Your telehealth program does not make your medication; a compounding pharmacy does. We listed every pharmacy the programs we review name on their own pages and looked each one up in FDA's public records.

Five of the 20 GLP-1 telehealth programs GLP Ranked reviews name the pharmacies that fill their compounded prescriptions: NexLife, Eden, Enhance.MD, IVIM Health and MEDVi. Together they name 19 pharmacies. Seven match an entry on FDA's compounding enforcement list, one has an open warning letter, and none made the fall 2026 GLP-1 recalls.

Takeaway: a named pharmacy is something you can check yourself in a few minutes. An FDA inspection report is not a finding of guilt, but an open warning letter or a recent recall is a reason to ask your program which pharmacy will fill your vial.

Why the pharmacy name matters more than the program name

Three companies stand behind a compounded GLP-1 bought through telehealth: the program takes your payment, a medical group writes the prescription, and a compounding pharmacy makes the drug. Only the last one touches what goes into your body.

Compounding pharmacies fall into two federal lanes. A 503A pharmacy (section 503A of the Food, Drug, and Cosmetic Act) compounds for individual prescriptions under its state board of pharmacy. A 503B outsourcing facility registers with FDA, follows current good manufacturing practice and is inspected on a risk-based schedule. FDA keeps a public list of registered outsourcing facilities; its version current as of November 17, 2026 is the one we used.

Neither lane makes the product FDA-approved: FDA's consumer page on unapproved GLP-1 drugs, current as of October 1, 2026, says the agency does not review compounded drugs for safety, effectiveness or quality before sale. The pharmacy's own record is one of the few independent signals a patient can look up.

Which programs name their pharmacies

We read the own pages of all 20 programs this site reviews on November 20 and 21, 2026: price pages, FAQs, terms and any pharmacy or medication-safety page. Five name at least one dispensing pharmacy. Zappy Health named The Pharmacy Hub and Hallandale Pharmacy on November 10; on November 21 its pages described "LegitScript-verified 503A compounding pharmacies" without a name, so it is not counted. Ro Body, Hims & Hers, bmiMD and TrimRx could not be read in full. Our pharmacy disclosure board keeps the full wording for every program.

Pharmacies named on each program's own pages, read November 20-21, 2026. Basis: first-party pages; the FDA column counts pharmacies with an entry on FDA's "Compounding: Inspections, Recalls, and other Actions" list (content current October 22, 2026).
ProgramWhere it names themPharmacies namedNumber namedWith an FDA list entry
NexLifePlan pages (its FAQ names the first and last only)Absolute Pharmacy (Lutz, FL); Premium Compounding (Decatur, AL); Boudreaux's New Drug Store (Lake Charles, LA)31
EdenGLP-1 page and about pageEden Pharmacy (its own; location not given); GoGoMeds (Southgate, KY); Precision (Bellmore, NY); Enovex (Glendale, CA); Absolute Pharmacy (Lutz, FL)51
Enhance.MDTerms of service and FAQRite-Away Pharmacy (San Antonio, TX); Vios Compounding (Livonia, MI); TruMedsRx (Fairfax, VA); Strive Pharmacy; Pharmacy Hub51 (Strive: location not given)
IVIM HealthMedication-safety pageEmpower Pharmacy (Houston, TX); Hallandale Pharmacy (Fort Lauderdale, FL); SBH Medical (Columbus, OH); Enovex (Los Angeles, CA); The Pharmacy Hub (Miami, FL); Olympia Pharmacy (Orlando, FL)64
MEDViTerms on its GLP-1 pagesTriad Rx (Daphne, AL); RedRock Pharmacy (St. George, UT); Beaker Pharmacy & Compounding (McKinney, TX)31

Counting each pharmacy once, the five programs name 19. We merged a name printed by two programs when the city matched, sat in the same metro area or was missing: Absolute Pharmacy (NexLife, Eden), Enovex (Glendale and Los Angeles) and The Pharmacy Hub (Enhance.MD gives no city). None of the five says which pharmacy will fill a given order.

Pharmacies named by each program, and how many have an FDA compounding-list entry Horizontal bars. NexLife names 3 pharmacies, 1 with an FDA entry. Eden names 5, 1 with an entry. Enhance.MD names 5, 1 with an entry. IVIM Health names 6, 4 with an entry. MEDVi names 3, 1 with an entry. NexLife3 named · 1 FDA entry Eden5 named · 1 Enhance.MD5 named · 1 IVIM Health6 · 4 MEDVi3 named · 1 0246 Number of pharmacies (dark: with an FDA compounding-list entry)
Chart: pharmacies named per program (light bar) and those with an entry on FDA's compounding enforcement list (dark bar). Source: programs' own pages read November 20-21, 2026; FDA list content current October 22, 2026. The table above holds the same numbers.

What FDA's records show for each named pharmacy

For every pharmacy we searched three public FDA sources on November 21, 2026: the agency's list of compounding inspections, recalls and other actions since 2019; the drug enforcement reports in the openFDA database, searched by recalling firm; and the registered outsourcing facilities list. We matched on the name and city each program printed.

FDA records for the named pharmacies with any entry, as read November 21, 2026. "483" is an inspection report of observations, not a final finding. Sources: FDA compounding actions list (content current October 22, 2026), openFDA drug enforcement reports, FDA registered outsourcing facilities (content current November 17, 2026); "503B registered" means a registered facility with a matching firm name and the phone number the program prints.
Pharmacy (named by)FDA compounding-list actions, newest firstRecalls in openFDA503B registered
Empower Pharmacy, Houston, TX (IVIM)503A facility: warning letters September 18, 2026 and April 2, 2025; 483s November 14, 2025, October 4, 2024 and December 1, 2023. 503B facility: 483 November 14, 2025; warning letter April 2, 2025; 483 August 28, 2024; earlier actions back to 2019, including a warning letter of October 15, 20214 Class II, 2023-2025 (none a GLP-1)Yes, since July 16, 2016
Olympia Pharmacy, Orlando, FL (IVIM)503B facility (OPS International): 483s September 3, 2026, August 8, 2025 (amended), May 29, 2024 and March 2, 2022; regulatory meeting February 22, 20234 recall events, 2013 and 2022 (none a GLP-1)Yes, since March 10, 2014
Hallandale Pharmacy (IVIM lists Fort Lauderdale; FDA lists Hallandale, FL)FMD-145 letter November 20, 2025; 483 June 13, 2025; warning letter March 11, 2020, closed out May 3, 20229 products, 2018 (none a GLP-1)No
SBH Medical (IVIM lists Columbus; FDA lists Worthington, OH)State referral and FMD-145 letters June 16, 2020; 483 September 30, 2019None foundNo
Absolute Pharmacy, Lutz, FL (NexLife, Eden)Warning letter close-out July 14, 2021; de-registered as an outsourcing facilityNone foundNo
Vios Compounding, Livonia, MI (Enhance.MD)State referral April 9, 2024; FMD-145 January 29, 2024; untitled letter September 18, 2023; 483 March 2, 2023None foundNo
Triad Rx, Daphne, AL (MEDVi)Warning letter close-out, state referral and FMD-145 May 3, 2023; 483 December 8, 2022; warning letter February 5, 2019None foundNo

Ten pharmacies had no entry on any of the three sources under the name and city printed: Eden Pharmacy, Premium Compounding, Boudreaux's New Drug Store, GoGoMeds, Precision, Enovex, Rite-Away Pharmacy, TruMedsRx (legal name Beauty Empower Rx, LLC), The Pharmacy Hub and Beaker Pharmacy & Compounding. Two more are uncertain. FDA lists a Strive Pharmacy in Boerne, Texas (483 issued September 8, 2023) and a new Strive Outsourcing facility in Alachua, Florida, but Enhance.MD does not say which Strive location it uses. FDA also lists a Red Rock Pharmacy in Springville, Utah (483 issued July 31, 2026), while MEDVi's GLP-1 page puts RedRock Pharmacy in St. George; its home page prints a northern Utah phone number for the same pharmacy, so the match is possible but unconfirmed.

How to read these records without overreacting

The records are not a scoreboard. A Form 483 lists what inspectors observed; FDA decides later whether action is needed. An FMD-145 letter releases FDA's inspection report to the firm. A warning letter is a formal notice of significant violations, and a close-out letter means FDA considers the matter resolved. A state referral hands the follow-up to the state board of pharmacy.

Inspection frequency skews the picture too. Registered outsourcing facilities such as Empower's and Olympia's are inspected on a schedule, so they collect more documents than a small 503A pharmacy FDA has never visited. A blank record can mean a clean history, or no FDA inspection since 2019.

Three facts stand out anyway. First, Empower's most recent warning letter, 738238 of September 18, 2026, is open on FDA's index, as are its April 2, 2025 letters. FDA wrote that Empower's compounded tirzepatide with niacinamide and semaglutide with cyanocobalamin "appear to be essentially copies of FDA-approved semaglutide and tirzepatide products" and cited insanitary conditions. IVIM Health lists Empower first among its compounding pharmacies. Second, the four compounded GLP-1 recalls classified this fall came from Carolina Infusion, Apothecary Pharma, Houston Rx and Victory Medical Center Pharmacy, and none of them is named by any program we review (see the news ledger). Third, every named pharmacy with a past warning letter, apart from Empower, shows a close-out.

A worked example: one program, three pharmacies

Take NexLife, the program ranked first on this site's computed scores. Its plan pages name three state-licensed 503A pharmacies, while its FAQ and newer guides name two, Absolute Pharmacy and Boudreaux's New Drug Store. Only Absolute appears on FDA's list, with a warning letter closed out on July 14, 2021; none of the three appears as a recalling firm in openFDA. The open question for a NexLife patient is which of the two or three pharmacies will fill the order, so ask before you pay.

For IVIM the same arithmetic gives six named, four with entries, one open warning letter and two that match registered outsourcing facilities. Neither profile proves anything about drug quality; both tell you what to ask.

What this means for you

  • If your program names its pharmacies, look each one up before your first shipment, using the steps below. An open warning letter does not mean your vial is unsafe, but it is fair to ask which site will fill your order.
  • If your program does not name one, ask in writing which pharmacy fills your prescription, and whether it is a 503A pharmacy or a 503B outsourcing facility. Keep the reply.
  • When the vial arrives, read the pharmacy name and lot number on the label. That name, not the program's brand, is what FDA's recall notices use.
  • Follow FDA's advice to discard a compounded multi-dose vial 28 days after first use.

How to check a pharmacy yourself

  1. Take the pharmacy name and city from your program's pages or vial label, open FDA's "Compounding: Inspections, Recalls, and other Actions" page and note any 483, letter or close-out under the firm's legal name.
  2. Search the FDA enforcement report database for the firm as the recalling firm, and check whether any recall names your drug or lot.
  3. Check FDA's registered outsourcing facilities list if the program says 503B.
  4. Look the pharmacy up on your state board of pharmacy's license search; state boards oversee 503A pharmacies. Our pharmacy verification guide walks through it.

Method and limits

Pharmacy names are as printed on the programs' pages; we did not contact the programs or the pharmacies. FDA's compounding list covers actions from 2019 onward. We searched openFDA by firm name, so a recall filed under a different legal name may be missed. The records describe the pharmacy, not the program, and a program can change pharmacies at any time. Ingredient sourcing is a separate question, covered in our green-list article.

Frequently asked questions

How do I find out which pharmacy fills my GLP-1 prescription?

Check the program's pharmacy, medication-safety or terms page first, then the label on your vial, which must name the dispensing pharmacy. If neither tells you, ask the program in writing which pharmacy fills your prescription and whether it is a 503A pharmacy or a 503B outsourcing facility, and keep the answer with your records.

Does an FDA Form 483 mean a pharmacy is unsafe?

No. A Form 483 lists conditions FDA inspectors observed during an inspection. The pharmacy responds, and FDA later decides whether further action, such as a warning letter, is needed. A 483 is a reason to ask questions, not proof that a product is unsafe or that the pharmacy broke the law.

Which named pharmacy has an open FDA warning letter?

Of the 19 pharmacies named by the programs we review, Empower Pharmacy in Houston has open warning letters, most recently 738238, dated September 18, 2026, about compounded tirzepatide with niacinamide and semaglutide with cyanocobalamin. IVIM Health names Empower on its medication-safety page. FDA's index showed no close-out when we read it on November 21, 2026.

Were any of the fall 2026 compounded GLP-1 recalls from these pharmacies?

No. The four compounded GLP-1 recalls classified in October 2026, and reported between October 14 and November 11, came from Carolina Infusion, Apothecary Pharma, Houston Rx and Victory Medical Center Pharmacy. None is named as a dispensing pharmacy by NexLife, Eden, Enhance.MD, IVIM Health or MEDVi, according to the pages we read on November 20 and 21, 2026.

Is a 503B outsourcing facility safer than a 503A pharmacy?

Not automatically. A 503B facility registers with FDA, must follow current good manufacturing practice and is inspected on a risk-based schedule, while a 503A pharmacy compounds for individual prescriptions under state board oversight. Both can produce good or bad batches, and neither makes a compounded drug FDA-approved. The record of the specific site matters more than the label.

What should I do if my pharmacy appears on a recall list?

Compare the product name and lot number on your vial with the recall notice. If they match, stop using the vial, keep it, and contact both your program and the pharmacy for a replacement and instructions. Report any side effects to your clinician and to FDA MedWatch. A recall of a different product from the same pharmacy does not cover your vial.

Researched By Dr. Parmis · Medical Researcher · Western University of Health Sciences

Medically Reviewed By Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)

Last medically reviewed: · This page is informational and does not constitute medical advice.

Sources

  1. FDA: Compounding: Inspections, Recalls, and other Actions — content current as of October 22, 2026; read 2026-11-21; regulator
  2. FDA: Registered Outsourcing Facilities — content current as of November 17, 2026; read 2026-11-21; regulator
  3. openFDA drug enforcement reports (searched by recalling firm) — API queries run 2026-11-21; regulator dataset
  4. FDA warning letter 738238 to Empower Clinic Services, LLC dba Empower Pharmacy — dated September 18, 2026; posted September 22, 2026; checked 2026-11-21; regulator
  5. FDA: Concerns with Unapproved GLP-1 Drugs Used for Weight Loss — content current as of October 1, 2026; read 2026-11-20; regulator
  6. openFDA: compounded tirzepatide recalls reported September-December 2026 — read 2026-11-20; regulator dataset
  7. NexLife: Compounded tirzepatide plans (pharmacies named) — read 2026-11-20; provider-reported
  8. NexLife: Frequently asked questions (two pharmacies named) — updated November 14, 2026; read 2026-11-20; provider-reported
  9. Eden: About (partner pharmacy information) — read 2026-11-21; provider-reported
  10. Eden: GLP-1 weight loss page (Eden Pharmacy) — read 2026-11-21; provider-reported
  11. Enhance.MD: Terms of service (pharmacy partners) — read 2026-11-21; provider-reported
  12. Enhance.MD: FAQ (current partnered pharmacies) — read 2026-11-21; provider-reported
  13. IVIM Health: Medication safety information (pharmacies) — read 2026-11-21; provider-reported
  14. MEDVi: GLP-1 program terms (partner pharmacies) — read 2026-11-21; provider-reported
  15. Zappy Health: Pharmacy partners — read 2026-11-21; provider-reported

Cite this page

GLP Ranked. "Which pharmacy fills your GLP-1 program? What FDA's records show for 19 named pharmacies." https://glpranked.com/journal/glp1-program-pharmacies-fda-records-2026/

GLP Ranked. "Which pharmacy fills your GLP-1 program? What FDA's records show for 19 named pharmacies." https://glpranked.com/journal/glp1-program-pharmacies-fda-records-2026/